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Program Evaluation on the Use of the Screening, Brief Intervention and Referral to
Treatment (SBIRT) Process in Primary Care Physician Offices
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SCREENING BRIEF INTERVENTION AND REFERRAL TO TREATMENT
Abstract
Screening, Brief Intervention, and Referral to Treatment (SBIRT) is an early screening
intervention tool for individuals with non-dependent substance use, which is employed to
identify and provide care before a patient needs extensive specialized treatment. SBIRT can be
used in primary care settings, to methodically screen individuals who might not seek help for a
substance use issue (Centers for Medicare & Medicaid Services, [CMS], 2020). Gaps in using
the SBIRT screening process were identified within the insurance organization’s PCP practices,
therefore, a program evaluation was completed to: (a) determine whether Primary Care
Physicians (PCPs) were using the SBIRT process, (b) identify the facilitators and barriers to
utilizing the SBIRT process, (c) determine the location and specialties of those PCP offices
utilizing and billing for SBIRT screening, and (d) provide recommendations to the healthcare
insurance organization. Quantitative and qualitative data revealed that the PCPs were not
utilizing the SBIRT process. The barriers and facilitators to utilizing the SBIRT screening
process found in the research literature paralleled the insurance organization’s SBIRT results.
Recommendations for implementing the SBIRT screening process within the PCP practices
include identifying SBIRT initiative resources and support, conducting roundtable discussions
with PCP providers to enlist their support and collaboration, establishing SBIRT champions
within practices, standardizing billing and payment policies for all payor sources, providing
educational opportunities on SBIRT billing and payment policies, and developing an SBIRT
Toolkit to support the PCP offices.
Keywords: Substance use disorder, brief intervention, referral to treatment, SBIRT process,
implementation, substance misuse, primary care, Substance Abuse and Mental Health Services
Administration.
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Program Evaluation on the Use of the Screening, Brief Intervention and Referral to
Treatment (SBIRT) Process in Primary Care Physician Offices
Introduction
The Substance Abuse and Mental Health Services Administration (SAMHSA) reports
that Substance Use Disorder (SUD) continues to reach epidemic proportions in the United States
(U.S.). (SAMHSA, 2019). Data from 2019 suggests that in the U.S. approximately 165.4 million
people aged 12 or older, were using substances such as tobacco, alcohol, or an illicit drug, in any
one months’ time. This includes 58.1 million people using tobacco, 139.7 million people using
alcohol, and 35.8 million people using illicit drugs (SAMHSA, 2019).
In the state of Pennsylvania the 2018-2019 data suggests that the overall illicit drug use in
any one month among individuals aged twelve years or older, was 10.6% -12.4% of the
population, or 1.2 million people (SAMHSA, 2020d). The data also shows that in the past year
marijuana use among individuals aged twelve years or older was between 14.8% and 16.3% of
the population, or 1.7 million people and heroin use was between 0.39% and 0.65% or forty-four
thousand people; somewhat higher than other states with a national average of 0.29% and 0.32%.
From 2018-2019 the number of people diagnosed with SUD in the state was 760,000 people
(SAMHSA, 2020b). The COVID-19 pandemic has exacerbated the nation’s drug overdose
epidemic (American Medical Association, 2021) and in 2020, the rate of opioid-related mortality
increased in more than 40 states (Abramson, 2021).
Screening, Brief Intervention, and Referral to Treatment (SBIRT) is an integrated and
comprehensive public health approach to early intervention and treatment for individuals at risk
of developing substance use disorders, as well as those already affected by these disorders.
hospital emergency rooms, primary care centers, and other community settings can provide the
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opportunity for early intervention with at-risk substance users before more severe use or harmful
consequences occur (SAMHSA, 2020). Quick screening can assess substance use severity and
identify appropriate levels of treatment. If needed, brief intervention then focuses on increasing
insight and awareness in relation to substance use and increased motivation toward behavioral
change. A referral to treatment will provide those who need more extensive treatment with a
connection to specialty care (SAMHSA, 2020a).
SBIRT is an early screening intervention tool to identify individuals with non-dependent
substance use and provide care before they need extensive specialized treatment. It is distinct
from the specialized treatment of those with more severe substance misuse, or patients meeting
criteria for SUD. SBIRT can be used in primary care settings, to methodically screen individuals
who might not seek help for a substance use issue, allowing access to SBIRT treatment services.
These services have been shown to decrease the severity of alcohol and drug use, reduce health
care costs, reduce risk of physical trauma, and reduce the percentage of individuals who go
without specialized treatment (CMS, 2020).
The healthcare insurance organization’s billing code data did not indicate that PCPs were
using the SBIRT screening process. Therefore, a program evaluation was completed to quantify
the use of the SBIRT process by the healthcare insurance organization’s PCP offices in the state
of Pennsylvania, and to identify the facilitators and barriers in utilizing the SBIRT screening
process.
Literature Review
A computerized literature search was performed using electronic databases which
included: CINAHL, PubMed, Medscape, Ovid, Cochrane Database of Systematic Reviews,
Joanna Briggs Institute, and Google Scholar. The search terms: substance use; brief intervention;
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referral to treatment; SBIRT screening; implementation; substance misuse; primary care; and
evaluation were used to identify articles published between 2016 and 2021. The synthesis review
was completed on 45 articles using the Johns Hopkins Evidenced-Based Practice Model (Dang
& Dearholt, 2018). Eighteen articles were identified along with six guidelines, and 10 studies
with quality ratings of good to high across levels I to V.
It is important to understand what is meant by the term “substance use disorder.” “The
Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) no longer uses the
terms substance abuse and substance dependence. Instead, it refers to substance use disorders,
which are classified as mild, moderate, or severe” (CMS, 2020, p. 3). SBIRT screens for SUD.
The United States Preventive Services Task Force (USPSTF, 2020) recommends that screening
should occur in primary care settings by asking those 18 years or older, questions regarding
unhealthy drug use. Also, the Kansas Department of Health and Environment (n.d.) states that
SUD occurs with the recurring use of drugs and/or alcohol and can cause clinically significant
impairment as well as disability, health problems, and a failure to meet work, home, or school
responsibilities. Therefore, it is imperative to screen patients to identify those at risk of health
issues or other problems relating to the use of drugs and/or alcohol. It can also identify patients
who have already developed problems. The National Council for Behavioral Health (2018)
recommends screening all adults at least once per year.
There are several differing screening tools which can be used, ranging between three to
five questions and full screening tools with an average of eight to 10 questions. The
recommended and most common pre-screening tools include: the National Institute on Drug
Abuse (NIDA) Quick Screen; a modified ASSIST pre-screening tool which assesses lifetime
usage of various substances; the Four Ps, a four question pre-screening clinical tool for prenatal
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substance use and abuse; the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a
three-item pre-screening tool for alcohol, used to assess drinking habits; and the World Health
Organization's Alcohol Use Disorders Identification Test-Consumption (AUDIT-C) (New York
State Office of Addiction Services and Supports, n.d.). Full screenings are given after a patient
has a positive screening outcome with a pre-screening tool. A series of validated questions to
assess the level of substance use are asked during the full screening process.
In order to comply with the National Council for Behavioral Health and the Substance
Abuse and Mental Health Services Administration (SAMHSA) recommendations, SBIRT
screenings should be implemented and conducted once per year (National Council for Behavioral
Health, 2018). Del Boca et al. (2017) discussed a conceptual framework for the implementation
of SBIRT services. The components of their framework include: SBIRT services provided,
performance site or setting, SBIRT providers, patients, and management. Successful
implementation of the framework components indicates reaching successfully intended target
populations, the program is tenable over time, and reduces the likelihood of major modifications
possibly jeopardizing evidence-based practice (Del Boca et al., 2017). Hargraves et al. (2017)
reviewed eight best practices for primary care providers implementing SBIRT screening. These
best practices include having a practice champion; utilizing an interprofessional team; defining
and communicating details of each SBIRT step with the team; developing relationships with
referral partners; instituting ongoing SBIRT training; aligning SBIRT flow within the existing
primary care office flow; considering the use of a pre-screening instrument; and integrating
SBIRT within the electronic health record (Hargraves et al., 2017).
Moser et al. (2020) report common barriers in the adoption of SBIRT in the primary care
setting that include: cost of adding services, lack of clarity of responsibility or role, timing of the
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intervention or screening during a visit, lack of training for all providers, lack of overall time,
lack of personnel or space, cost of reimbursement, and inability to adapt the workflow in a
relevant manner. A study conducted by Vendetti et al. (2017) looked at SBIRT grant programs
and modifications in program design that address facilitators to SBIRT implementation. The
study found six themes relating to facilitation of implementation. These themes included: having
committed leaders, communication and collaboration, factors regarding context, modelacceptance and provider buy in, grant requirements, and quality assurance. The study also found
that over time programs had a tendency to use contracted specialists to perform the SBIRT
screening and services, to adopt more efficient pre-screening tools, to screen for risk factors as
well as substance or alcohol use, and the implementation of both on-site and telephone treatment
delivery (Vendetti et al., 2017).
A separate study by Barbor et al. (2017) looked at another cross-site evaluation of a
national SAMHSA SBIRT program. This study reviewed major findings and implications of the
program which screened over one million patients. They concluded that the pre-and post-changes
were clinically meaningful and significant for the majority of substance use measures.
Implementation had been facilitated by substance use specialists and committed leadership. A
large percentage of the original performance sites in the program adapted and redesigned the
delivery of SBIRT after the initial grant funding ended (Barbor et al., 2017).
Aldridge et al. (2017) reviewed outcomes and estimated the changes relating to the
substance use of patients who received service as part of the SAMHSA grant program. Their
study compared substance use behavior among 17, 575 patients before and six months after
SBIRT service. They found “large and statistically significant decreases for almost every
measure of substance use” (p.43).
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Sociotechnical Model
The Action-Network Theory (ANT) is the sociotechnical model to be used to assess the
impact of technology in this program evaluation. ANT is based upon the premise that everything
in the environment or situations are actors playing an active role in the system, and that nothing
and no one plays a passive role. This creates a network system based upon interaction rather than
a linear system based upon layers or hierarchy. McBride and Tietze (2019) point out “actors are
dynamic entities that may possess agency well beyond their immediate contexts or
environments” (p. 54). Under the ANT model, other actors to be included as part of the
population that might impact the DNP project are attitudes of the providers, ease of using the
screening tool, and the complexity of the billing system. When applying the ANT sociotechnical
perspective to the assessment of the impact of technology, there are several actors to be
considered. First, the insurance organization’s billing system codes act as an actor that might
have a great impact on the project. If the providers are implementing the SBIRT screening tool
but not billing for the tool, why are they not billing for the tool? Do they know that they can bill
for the tool, that an SBIRT billing code exists in the system, or which billing code is to be used?
A second actor under the ANT sociotechnical perspective, would be the SBIRT tool itself and its
ease of use. Other actors to consider would be provider attitudes, and patient attitudes. The ANT
sociotechnical perspective will be used to help identify undiscovered variables that may exist in
this healthcare environment.
WK Kellogg Evaluative Framework
Program evaluations identify opportunities which can impact change and improve the
quality of care that patients receive. The W.K. Kellogg Foundation (WKKF) Step-by-Step Guide
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to Evaluation (2017) was chosen for this program evaluation. The following are steps involved in
the W. K. Kellogg Foundation (2017) framework:
1.

Prepare for conducting an evaluation.

2.

Determine the stakeholders and when/ how to engage them.

3.

Identify any assumptions; determine theory of change and logic model.

4.

Develop evaluation plan.

5.

Collect and analyze data.

6.

Communicate results to interpret findings to facilitate learning.

7.

Make informed decisions (W.K. Kellogg Foundation, 2017).

This approach to program evaluation is an effective tool to evaluate and inform the progress
made on the strategies that have been implemented. The steps listed will be discussed throughout
the manuscript.
Description of the Project
Aims and Objectives
The purpose of this program evaluation was to quantify the use of the SBIRT process by
the insurance organization’s PCP offices in the state of Pennsylvania, and to identify the
facilitators and barriers to the utilization of SBIRT within those PCP offices. Aims and
objectives were identified in collaboration with the insurance organization’s project stakeholders
including an interdisciplinary team consisting of mid-management directors of Behavioral
Health, Mental Health and SUD programs and included:
1. Evaluate use of the SBIRT process in the insurance organization’s PCP offices.
a. Collect baseline insurance billing data to identify and quantify providers billing
use for SBIRT and SUD screenings.
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b. Identify financial consequences of missed utilization of SBIRT screening tool
through cost-benefit analysis, and to identify patient consequences of missed
utilization.
2. Gather information to identify reasons why the SBIRT process is or is not being
used by the insurance organization’s PCP practices.
a. Obtain input from stakeholders to develop an evaluation strategy.
b. Collect data using interviews/survey, regarding use of SBIRT in the PCP
practices.
c. Collect data using interviews/survey to identify barriers and facilitators to the
implementation of SBIRT in the PCP practices.
3. Provide outcome findings and recommendations to the insurance organization’s
stakeholders on increasing utilization of the SBIRT process within their PCP
offices. Compare and contrast organizational SBIRT protocol with national
standards and guidelines - identify gaps in their process.
a. Create an SBIRT workflow process for utilization in PCP offices.
b. Complete a formal written document and presentation for stakeholders to share
outcomes, recommendations, and next steps.

Overview of Methodology
Program Evaluation
A process/formative program evaluation was completed to determine if the SBIRT
screening tool process had been implemented as planned in the PCP offices. A case-study
methodology was used with a focus on understanding the SBIRT screening tool process. The
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evaluation also examined if the process was producing the intended outputs, along with
identifying facilitators and barriers of utilizing the SBIRT screening tool process (WKKF, 2017).
The Logic Model in Table 1 was developed in collaboration with the stakeholders. The
inputs and outputs involved the participation and collaboration of the project team members in
order to develop the survey design, dissemination, and analysis of the survey results as well as
follow-up interviews conducted. A cost-benefit-analysis was also completed.
Table 1
Program Evaluation Logic Model
Inputs









Stakeholde
r
Evaluator
Behavioral
Health
Substance
Use
Services
Departmen
t
Research
Marketing
PCP
Offices
Patients

Activities










Survey
designed
and
created
Survey
Rolled
out
Data
compile
d
Data
analyzed
Report
compile
d
Intervie
w
question
s written
Billing
data
collected

Outputs








Participation
collaboratio
n of Primary
Care
Providers
Collaboratio
n with
Substance
Use Services
Department
Survey
questions
created
Interviews
Cost-Benefit
analysis

Short-term
Outcomes






Survey
questionnaire designed and
distributed
Data
collected
and
analyzed
Interviews
conducted
if possible

Intermediate
Outcomes







SBIRT
screening
use
identified
and
quantified
Facilitators
and/or
barriers
ascertained
SBIRT best
practice
identified
Recommend
ations
provided

Long-Term
Outcomes




SBIRT
implemented
across sites
Reduced risky
substance use
Improved
overall
community
health

Note: Adapted from “Understanding and Applying Program Logic Models,” by J. McDavid, I.
Huse and L. Hawthorn, 2019. Program Evaluation and Performance Measurement: An
Introduction to Practice, p. 55, copyright 2019 by SAGE Publications, Inc.
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Once the Logic Model was completed the stakeholders were instrumental in developing the
list of program evaluation questions to be answered:
1. Are the providers using the SBIRT process according to national guidelines (at least once
per year per patient)?
a.

If so, are the SBIRT billing codes utilized?

b.

Which PCP specialties are utilizing SBIRT billing codes, most often?

c. Which areas in PA are utilizing SBIRT billing codes, most often?
d. If not, are the providers utilizing SUD screening and billing codes?
e. Do the providers know the difference between SUD screening and
SBIRT?
2. What are the identified facilitators/barriers to SBIRT utilization?
3. What is the cost benefit of increasing utilization of SBIRT?
4. Based on national standards, what are the recommendations to increase utilization of
SBIRT in organization’s PCP offices?
Setting and Population
This program evaluation was conducted between August 2020 to July 2021. It included
the insurance organizations 17,635 PCP practices, Internal Medicine, and specialty practices,
throughout the state of Pennsylvania. The program evaluation project was approved by the
University Institutional Review Board.
Implementation
Data Management Plan
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The first step in the SBIRT program evaluation was to determine the utilization rate for
the use of any SBIRT screening tools in the insurance organization’s PCP offices. The billing
data was compiled and reviewed to obtain baseline information using descriptive statistics. The
data collected for the SBIRT program evaluation involved 2019 billing data that included SBIRT
and SUD related billing codes, CPT 99408, CPT 99409, and G0442, used by the 17,635 PCP
practices. A cost-benefit analysis was also completed to identify the financial consequences of
missed utilization of the SBIRT screening process.
A mixed-method survey to obtain qualitative and quantitative data was designed with
input from the project team members, and distributed to 125 PCP offices electronically. The
survey questions focused upon SBIRT knowledge and usage, as well as any known facilitators or
barriers to the use of the SBIRT screening process within the PCP practices. The survey was
created through Qualtrics and distributed through the Chief Medical Officer’s email to increase
response. Post-survey follow-up interviews with the PCP practices were planned to expand upon
individual PCP usage, possible facilitators and/or barriers, as well as to identify any SBIRT
workflow processes successfully being used in order to create a workflow process for the PCP
offices, in general. The billing code data, as well as the survey and interview responses were to
be used to compare and contrast the insurance organization’s PCP practices to national standards
and guidelines, and to provide recommendations. A presentation and written document to share
the program evaluation outcomes, recommendations, and next steps will also be provided to the
healthcare insurance organization.
Program Evaluation Results
Quantitative Results - SBIRT Screens
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As noted earlier, the insurance organization managed 17, 635 PCP practices in the state
of Pennsylvania with 334,310 providers. Due to the unknown number of patients, utilization
rates were unable to be determined. However, the billing data showed that in 2019, there were a
total of 90,681 SBIRT screenings and a total of 17,461 SUD screens performed. In order to
determine where in Pennsylvania these screenings were occurring, both the SBIRT and SUD
screening data was broken down by zip code and provider specialty, with the top ten producing
zip codes and specialties charted on a map of Pennsylvania counties as noted in Figure 1 below.
Figure 1
SBIRT Screens in Pennsylvania Counties

The 2019 SBIRT data showed zip code 15601, Westmoreland County, Greensburg,
Pennsylvania produced the most amount of SBIRT screenings at 18,891. The second most
productive zip code regarding SBIRT screenings was almost 50% less at 9,208 screenings in
Butler County, Cranberry Township. The number of remaining screenings ranged from 6,984 to
4,094 with zip code 15644, Westmoreland County, Jeannette, Pennsylvania rounding out the top
ten zip codes. (see Appendix B).
To identify the providers who are performing the SBIRT screening processes in this
insurance organization, the top ten zip codes were reviewed. As shown in Appendix C, the
specialty of Internal Medicine performed the most SBIRT processes with 14,385 screenings. The
second top SBIRT producing specialty was Family Practice with 13,955 screenings. The least
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SBIRT productive specialty was Mental Health Rehabilitation at two SBIRT screenings
performed. The total SBIRT screenings performed by all specialties within the top ten producing
zip codes in Pennsylvania equaled 63,219.
Quantitative Results - SUD Screens
The 2019 SUD billing data showed that zip code 16001, Butler County, Butler, PA,
performed the most SUD screenings with 2,018 screens. The second most productive zip code
regarding SUD screenings was 15401, Fayette County, Uniontown, PA with 1,251 screens. After
this the number of SUD screenings ranged from 1,001 to 465 with zip code 16673, Blair County,
Roaring Spring, Pennsylvania rounding out the top ten zip codes (see Appendix D). As seen with
the SBIRT data, the SUD screening data showed that the majority of SUD screening occurred in
the Western counties within Pennsylvania as shown below in Figure 2.
Figure 2
SUD Screens in Pennsylvania Counties

To determine who is performing the SUD screens in this insurance organization the top
provider specialties performing SUD screening within the top producing zip codes were
reviewed. As shown in Appendix E, Family Practice performed the most SUD screens with
5,676 screenings. The second top producing specialty screening for SUDs was Internal Medicine
with 2,889 screenings. The least productive specialty for SUD screenings was General Practice
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with 45 screenings. The total SUD screenings performed by all specialties within the top ten
producing zip codes in this insurance organization equaled 8,792.
This data showed that the provider specialties within the top 10 zip codes are performing
70% of the total 2019 SBIRT interventions in all of Pennsylvania, and 50% of all the 2019 SUD
screenings within the state of Pennsylvania. It also showed that the top two producing PCP
specialties providing SBIRT screenings are Internal Medicine and Family Practice, and the top
two PCP specialties providing SUD screens are Family Practice and Internal Medicine.
Cost Benefit Analysis
A cost-benefit analysis (see Appendix F) was performed to determine the
financial consequences of not utilizing and billing the SBIRT screening tools. Total training on
SBIRT and educational material costs equaled $134,740. Assuming that each of the 17,635
practices performed 25 SBIRT screening processes per year, 440,875 SBIRT screenings would
be completed. The total benefit to the insurance organization is dependent upon the billing code
used, which is dependent upon time spent with patient. This produces gross revenue of
$14,729,634 - $28,881,721, prior to applying any billing code percentages and payor mix. It is
evident that additional revenue can be obtained by utilizing and billing for the SBIRT screening
tools. The intangible patient benefits identified in this CBA included decreased overdose rates,
decreased mortality, and decreased morbidities (Paltzer et al., 2017; American Society of
Addiction Medicine, 2017).
Qualitative Results: Survey Response
The 12-question mixed method survey was distributed randomly to 125 practices
through the insurance organization’s email. Of the 125 surveys distributed, there was one
response with greater than 80% of the surveys remaining unopened. This was a major unintended
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consequence and was not expected. A twelve-question interview was then completed with the
organization’s mid-management team. The team included managers and directors from the
Behavioral Health Department, Mental Health Department, SUD Department, Behavioral
Integration, Behavioral Health Authorization Reviews, and Strategic Management/Data
Management. The interview questions were based upon the original PCP survey questions (see
Appendix G) in order to ascertain mid-management perspectives regarding SBIRT utilization
and the facilitators and barriers to utilization within the individual PCP practices.
The information gathered during this interview session identified some important
elements concerning the SBIRT screening process. Overall, the sentiment of this group was that
the PCP offices do not know how to use or bill for SBIRT screenings and that they are not
comfortable performing these screenings.
The interprofessional mid-management team believed the barriers to SBIRT
implementation seen within the PCP practices are related to: no incentive for increased work; not
aware of codes; not aware of how to use the form; not comfortable asking questions about
SUD/mental health; not enough time; provider would not know what to do if a screen was
positive; do not know where to refer; PCPs inclined to send to specialists; the physicians prefer
“Dr to Dr approach” regarding education; and no training – staff do not feel competent. The team
believed the following facilitators could increase SBIRT utilization:


Registered Nurse/Social Worker Care Managers can serve as champions working with
the PCP and specialty practices.



Include physician input and collaboration in order to provide “Dr. to Dr. approach.”



Create PCP SBIRT Tool Kits to educate on a variety of topics.



Incorporate SBIRT and billing codes within EHR.
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An SBIRT workflow process diagram based on best practices within this insurance organization
was not able to be obtained due to the lack of survey responses. Therefore, a flow chart for
utilization in the PCP offices, was created based on national standards and SAMHSA guidelines
(2011) and can be found in Appendix H.
Limitations
The major limitation was the COVID-19 pandemic and the inability to meet face to face
with stakeholders and providers. The lack of response from the PCP offices to the survey limited
the ability to gather information on provider perspectives of SBIRT, as well as their views of
facilitators and barriers to the SBIRT screening and billing processes.
Summary and Interpretation
As seen in the research, the healthcare insurance organization’s SBIRT utilization rate
could not be determined. Hargraves, et al. (2017) state that across the United States, SBIRT
utilization rates have not been determined due to lack of data. This was also seen in the insurance
data for SBIRT and SUD screens. In the literature review, the USPSTF (2020) identified
important gaps related to unhealthy substance use screening. Gaps in SBIRT practice were also
identified within the healthcare insurance organization’s PCP practices. The gaps and barriers to
SBIRT implementation described in the literature, such as lack of time, training, lack of role
clarity, stigma, and reimbursement challenges, paralleled the healthcare insurance organization’s
SBIRT results (Hargraves et al., 2017; Vendetti et al., 2017). The facilitators to SBIRT
implementation alluded to by the mid-management team, including provider buy-in,
collaboration, leader commitment, and communication with referral partners was also paralleled
in the literature review (Hargraves et al., 2017; Vendetti et al., 2017).
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The billing data identified and quantified the PCP offices that were billing for SBIRT and
SUD screenings. It identified financial consequences of missed utilization of SBIRT screenings
through a cost-benefit analysis as well as the patient consequences of missed utilization of the
SBIRT screening process. The data obtained in this program evaluation provides a baseline to be
used in a new SBIRT screening process initiative and new opportunities to develop and
strengthen nursing and social worker Care Managers as SBIRT champions to support a new
SBIRT initiative project.
Conclusions and Recommendations
SBIRT is a dynamic tool with the ability to enable PCPs and specialty physicians to
identify and treat patients with substance use issues before SUDs occur. It has the ability to
decrease patient healthcare utilization and costs, thereby increasing positive patient outcomes
(Paltzer et al., 2019).
The literature reviewed best practices for SBIRT implementation, such as creating a
practice champion position, communicating and defining a SBIRT workflow process in detail,
creating a network and relationship with referral partners, implementing ongoing SBIRT
training, and utilizing an interprofessional team (Hargraves et al, 2017). These best practices
paralleled what the healthcare insurance organization’s mid-management team alluded to as
potential facilitators to SBIRT implementation, and are recommendations moving forward with
their SBIRT screening process initiative.
Additionally, it was recommended to have a roundtable discussion with an
interprofessional team, including physicians, to determine best practices within the individual
PCP and specialist offices. Implementing a Care Manager Champion position, along with staff
and provider training and education on the workflow of the SBIRT screening process and the
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appropriate coding and billing was also recommended. Networking within the community to
begin developing relationships with referral partners also needs to be strategized.
An SBIRT workflow process diagram for utilization in PCP offices and a formal written
document and presentation for stakeholders to share outcomes, recommendations, as well as next
steps was created and provided to the healthcare insurance organization. This program evaluation
created a sense of urgency for them to refocus and restart their SBIRT screening process
initiative. Together, these recommendations may increase utilization of SBIRT screenings with
the potential to improve positive patient outcomes regarding substance use, and enhance the
revenue for the healthcare insurance organization.
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Appendix A
Data Management Plan
______________________________________________________________________________
Data Collected

Data Management Data
Strengths
Limitations
& Data Display
Analysis
______________________________________________________________________________
Use of SBIRT tool
insurance billing
data from Health
Plan PCPs.

Excel
spreadsheet;
charts and/or
graphs.

Descriptive
Statistics.

Will allow the
determination of
utilization rate of
SBIRT tool.

Billing data for use
of SBIRT screening;
referral data for
Substance Use
Disorder (SUD);
billing data for SUD
treatment within any
Health Plan provider
offices

Excel
spreadsheet;
charts and/or
graphs.

Descriptive
Statistics.

Input from
stakeholders

Excel
spreadsheet;
charts and/or
graphs.
Excel
spreadsheet;
charts and/or
graphs.

Descriptive
Statistics.

Can be used to perform
cost-benefit analysis,
missed return on
investment and financial
consequences of missed
billing opportunities.
Can also be used to infer
possible patient
consequences and cost
of missed utilization
Can provide
information, ideas,
direction and guidance

Descriptive
Statistics.

Can provide information
on reasoning behind use
or non-use
Can provide information
on benefits/limitations

Excel
spreadsheet;
charts and/or
graphs.

Descriptive
Statistics.

Can be used to create
workflow chart to
compare and contrast to
National Standards and
SBIRT Logic Models.

Individual provider
uses of SBIRT tool
and workflow
process collected
through
survey/questionnaire
Workflow process
of expected Health
Plan SBIRT
utilization

Percentage of
primary care
provider offices
surveyed may be
limited
Percentage of
primary care
provider offices
surveyed may be
limited

Participant bias

Participant bias

______________________________________________________________________________
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Appendix B
Top 10 Screening, Brief Intervention and Referral to Treatment (SBIRT) Screens
in Pennsylvania Zip Codes
________________________________________________________________________
Zip Code & County
SBIRT Screens
_________________________________________________________________________
15601: Westmoreland County, Greensburg
18,891
16066: Butler County, Cranberry Township

9,208

16501: Erie County, Erie

6,984

16001: Butler County, Butler

5,875

15206: Allegheny County – Pittsburgh, Sharpsburg

4,817

15701: Indiana County –

4,725

15132: Allegheny County – McKeesport, White Oak

4,606

15237: Allegheny County – Ross, Franklin & McCandless Townships

4,552

15901: Cambria County – Johnstown

4,481

15644: Westmoreland County – Jeannette

4,094

___________________________________________________________________________
Note. Data obtained through review of Insurance Organization’s SBIRT billing data, 2019.
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Appendix C
Screening, Brief Intervention and Referral to Treatment (SBIRT)
Top Provider Specialties In Top 10 Zip Codes
______________________________________________________________________________
Specialty
SBIRT Screens
______________________________________________________________________________
Internal Medicine
14,385
Family Practice
13,955
Anesthesiology
9,035
General Practice
6,780
Pediatrics
5,143
Emergency Medicine
2,969
PCP OB/GYN
2,210
Physician Assistant
1,943
Physician Assistant in PCP
1,933
Surgery
1,239
Public Health & General Prevention
1,239
Pain Management
845
CRNP w/o Prescribing Authority BH
349
Pulmonary Diseases
261
Physical Medicine & Rehabilitation
192
Neonatal/Perinatal Medicine
177
Psychiatry
158
Hematology/Oncology
146
Neurology
143
Gynecology
115
Mental Health Rehabilitation Facility
02
______________________________________________________________________________
Note. Data obtained through review of Insurance Organization’s SBIRT billing Data, 2019.
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Appendix D
Top 10 Substance Use Disorder (SUD) Screens
in Pennsylvania Zip Codes
________________________________________________________________________
Zip Code & County
SUD Screens
_________________________________________________________________________
16001: Butler County, Butler
2,018
15401: Fayette County, Uniontown

1, 251

15090: Allegheny County – Wexford, McCandless & Franklin Park
Townships

1,001

16117: Lawrence County – Ellwood City

959

15237: Allegheny County – Pittsburgh: Ross & McCandless Townships

877

15146: Allegheny County – Pittsburgh: Monroeville

644

15218: Allegheny County – Pittsburgh: Swissvale, Edgewood

590

15425: Fayette County – Connellsville

509

15423: Washington County – California

478

16673: Blair County – Roaring Spring

465

___________________________________________________________________________
Note. Data obtained through review of Insurance Organization’s SUD billing data, 2019.

28

SCREENING BRIEF INTERVENTION AND REFERRAL TO TREATMENT

29

Appendix E
Substance Use Disorder Screening
Top Provider Specialties In Top 10 Zip Codes
___________________________________________________________________________
Specialty
SUD Screens
___________________________________________________________________________
Family Practice

5,676

Internal Medicine

2,889

Gynecology/OBGYN

101

Physician Assistant (PCP Office)

80

General Practice

45

Total

8,791

____________________________________________________________________________
Note. Data obtained through review of Insurance Organization’s Substance Abuse Disorder
billing Data, 2019.
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Appendix F
Cost-Benefit Analysis
______________________________________________________________________________
Total Costs: $134,740.
Training and educational materials.
Insurance Organization Benefits:
SBIRT billing code 99408

15-30min

$33.41

SBIRT billing code 99409

˃ 30min

$65.51

IF each of the 17,635 practices did 25 SBIRT process per year
17,635 x 25 = 440,875
440,875 x $33.41 = $14,729,634
440,875 x $65.51 = $28,881,721
Total Organizational Benefit Range:
$14,729,634 - $28,881,721 Dependent on Billing Code Used
______________________________________________________________________________
Note. Data obtained through review of Insurance Organization’s SBIRT billing Data, 2019. Does
not include payor mix calculations.
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Appendix G
Interview Questions
______________________________________________________________________________
1.

What are your perceptions of the use of the SBIRT process in the PCP or specialty practices? Is it being
used? Who does the screen? Who bills for the screen(s)?

2.

Have you heard of any facilitators that have supported the use of the SBIRT process?

3.

Have you heard of any barriers that have prevented the use of the SBIRT process?

4.

Do you think the offices know how to use the SBIRT screening tool versus the SUD, Depression,
Anxiety tools?

5.

Do they know the different billing codes to use for each tool?

6.

Can more than one billing code be used in the same visit?

7.

How was the SBIRT screening tool implemented to the practices? Has this implementation differed
from the original plan? Why might that be?

8.

Do you think that offices would benefit from education around SBIRT, other screens, and billing codes?

9.

What is the best way to provide that education from your perspectives?
o

In-person Presentation

o

Virtual presentation

o

On-line self-led training

o

Manual

o

Other: ____

10. What approach do you think might work to engage the offices to discuss SBIRT to identify a process
that works for the insurance organization since the survey did not work?
11. Do you think offices would be willing to participate in a work group to identify best practice for using
SBIRT screening tool as well as appropriate billing codes?
12. How does the insurance organization communicate changes in practices, such as SBIRT, to their
practices for implementation?

______________________________________________________________________________
Note: Mid-management team interview questions based on Insurance Organization PCP survey
questions, 2021.
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Appendix H
SBIRT Flowchart
_____________________________________________________________________________

_____________________________________________________________________________________
Note. SAMHSA. (2011). Screening, Brief Intervention and Referral to Treatment (SBIRT) in behavioral
healthcare. https://www.samhsa.gov/sites/default/files/sbirtwhitepaper_0.pdf

